Exact Sciences CorporationExact Sciences CorporationExact Sciences Corporation

Exact Sciences Corporation

No trades
See on Supercharts
Market capitalization
‪11.59 B‬USD
−1.14USD
‪−204.15 M‬USD
‪2.50 B‬USD
‪179.65 M‬
Beta (1Y)
1.67

About Exact Sciences Corporation

CEO
Kevin T. Conroy
Headquarters
Madison
Employees (FY)
‪6.6 K‬
Founded
1995
ISIN
US30063P1057
FIGI
BBG000CWL0F5
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EXAS is 63.22 USD — it has decreased by 1.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Exact Sciences Corporation stocks are traded under the ticker EXAS.
Exact Sciences Corporation is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
EXAS stock is 6.14% volatile and has beta coefficient of 1.67. Check out the list of the most volatile stocks — is Exact Sciences Corporation there?
One year price forecast for Exact Sciences Corporation has a max estimate of 115.00 USD and a min estimate of 66.00 USD.
Exact Sciences Corporation revenue for the last quarter amounts to ‪628.34 M‬ USD despite the estimated figure of ‪616.79 M‬ USD. In the next quarter revenue is expected to reach ‪638.83 M‬ USD.
Yes, you can track Exact Sciences Corporation financials in yearly and quarterly reports right on TradingView.
EXAS stock has fallen by 11.94% compared to the previous week, the month change is a 8.61% rise, over the last year Exact Sciences Corporation has showed a 5.09% decrease.
EXAS net income for the last quarter is ‪−49.77 M‬ USD, while the quarter before that showed ‪794.00 K‬ USD of net income which accounts for ‪−6.37 K‬% change. Track more Exact Sciences Corporation financial stats to get the full picture.
Today Exact Sciences Corporation has the market capitalization of ‪11.48 B‬, it has decreased by 3.27% over the last week.
No, EXAS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EXAS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Exact Sciences Corporation stock right from TradingView charts — choose your broker and connect to your account.
EXAS reached its all-time high on Jan 25, 2021 with the price of 159.54 USD, and its all-time low was 0.22 USD and was reached on Nov 21, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪6.60 K‬ employees. See our rating of the largest employees — is Exact Sciences Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Exact Sciences Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Exact Sciences Corporation stock shows the sell signal. See more of Exact Sciences Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Exact Sciences Corporation future price: according to them, EXAS price has a max estimate of 115.00 USD and a min estimate of 66.00 USD. Read a more detailed Exact Sciences Corporation forecast: see what analysts think of Exact Sciences Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Exact Sciences Corporation EBITDA is ‪−77.47 M‬ USD, and current EBITDA margin is −3.05%. See more stats in Exact Sciences Corporation financial statements.